Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05597306 · RECRUITING

Trial details

NCT number: NCT05597306
Sponsor: Terrence J Bradley, MD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia, in Relapse

Start date: 2022-11-19
Primary completion: 2026-11-19
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.